|
|
Volumn 130, Issue 2, 1999, Pages 155-157
|
|
A novel antimicrobial agent joins the battle against resistant bacteria
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
DALFOPRISTIN;
DAPTOMYCIN;
EPEREZOLID;
EVERNINOMICIN;
L 786392;
LINEZOLID;
N [[3 (4 ACETYLPHENYL) 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE;
N [[3 [4 (METHYLSULFINYL)PHENYL] 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE;
ORITAVANCIN;
OXAZOLIDINONE DERIVATIVE;
PRISTINAMYCIN;
QUINUPRISTIN;
RAMOPLANIN;
SYNEREID;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERICIDAL ACTIVITY;
BACTERIOSTASIS;
CHEMICAL MODIFICATION;
DRUG FORMULATION;
EDITORIAL;
ENTEROCOCCUS FAECIUM;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
|
|
EID: 0033582163
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-130-2-199901190-00012 Document Type: Editorial |
|
Times cited : (67)
|
|
References (19)
|